miR-218-5p、HMGB1在过敏性紫癜患儿外周血中的表达及临床意义

目的 探讨miR-218-5p与HMGB1在HSP、HSPN患儿外周血的表达及临床意义。方法 选择过敏性紫癜(Henoch-Schnlein purpura, HSP)、紫癜性肾炎(Henoch-Schnlein purpura nephritis, HSPN)住院患儿各30例作为实验组,门诊体检儿童30例作为对照组。采用RT-PCR技术检测外周血中miR-218-5p的表达,ELISA法检测外周血中HMGB1的表达,观察3组儿童中miR-218-5p、高迁移率族蛋白1(high-mobility group box-1, HMGB1)的表达水平,同时分析HSP组、HSPN组两组间白细胞计数(white blood cell, WBC)、中性粒细胞绝对计数(absolute neutrophil count, ANC)、淋巴细胞绝对计数(absolute lymphocyte count, ALC)、红细胞计数(red blood cell, RBC)、血小板计数(platelet, PLT)、尿素(urea, UREA)、肌酐(creatinine, CRE)、尿酸(uric acid, UA)的表达。结果 miR-218-5p表达在对照组、HSP组、HSPN组逐渐降低; HMGB1表达在对照组、HSP组、HSPN组逐渐增高; miR-218-5p、HMGB1、WBC、ANC与肾脏损伤发生差异有统计学意义;而ALC、RBC、UREA、CRE、UA与肾脏损伤发生差异无统计学意义;miR-218-5p是HSP患儿发生肾脏损伤的独立保护性因素,HMGB1是独立危险性因素;miR-218-5p在HSP发展过程中诊断肾脏损伤的最佳截断值为0.515,敏感度为100.0%,特异性为76.7%;HMGB1诊断肾脏损伤的最佳截断值为3348.2pg/ml,敏感度为86.7%,特异性为90.0%。结论 miR-218-5p可能通过靶向调节HMGB1的表达参与HSP、HSPN的发病机制,并且与病情严重程度相关,有望成为HSP患儿的生物学靶点。     

外泌体微RNA治疗骨关节炎研究进展

骨关节炎是骨科常见的顽固性疾病之一,因其高发病率、高致残率,给患者和社会带来沉重的负担。随着组织工程领域的飞速发展,外泌体治疗骨关节炎的潜力已得到证实。其中,外泌体特异性微RNA（miRNA）可抑制软骨降解和滑膜炎症、促进软骨下骨重塑,从而缓解甚至逆转骨关节炎的病理改变。本文对外泌体miRNA治疗对骨关节炎患者软骨、滑膜、软骨细胞外基质及软骨下骨的影响进行综述,以期为临床上应用外泌体miRNA治疗骨关节炎提供参考。     

胃癌术前淋巴结转移评估方法研究进展

胃癌在我国的发病率及病死率较高,目前,手术仍然是胃癌的主要治疗方式。术前诊断淋巴结转移对于胃癌手术方式的选择有着重大意义。目前,临床中对于胃癌术前淋巴结转移的诊断尚没有金标准。本文对胃癌术前淋巴结转移评估方法的研究进展进行综述。     

基因诊断技术在脊柱结核诊断中的应用现状

脊柱结核是一种常见的肺外结核病。近年来,随着脊柱结核患者逐年增多,不典型脊柱结核患者亦逐渐增多,而不典型脊柱结核诊断较为困难,需要与一般细菌感染、肿瘤以及非结核分枝杆菌感染相鉴别。基因诊断技术是一项诊断脊柱结核的重要工具,对临床不典型脊柱结核的诊断有较高价值。本文将对脊柱结核的流行现状、诊断及基因诊断技术进行综述,以帮助临床工作者对脊柱结核做出更加准确的诊断。     

银离子、铜离子和锌离子对常见念珠菌的抗菌性能比较

目的 探讨银离子(Ag⁺)、铜离子(Cu²⁺)、锌离子(Zn²⁺)对5种常见念珠菌(白色念珠菌、热带念珠菌、近平滑念珠菌、克柔念珠菌和光滑念珠菌)的抗菌作用。方法 使用去离子水分别将硝酸银、氯化铜和氯化锌配制为0.1 mol·L^-1的水溶液。取保存的白色念珠菌标准菌株ATCC-60193、近平滑念珠菌、光滑念珠菌、热带念珠菌、克柔念珠菌,加入溶菌肉汤培养液,使用比浊仪调配菌液浊度为0.5麦氏单位,然后使用无菌去离子水将菌液稀释至10⁶ CFU·L^-1。取配制好的0.1 mol·L^-1的硝酸银、氯化铜和氯化锌溶液,分别倍比稀释为6个浓度(10^-2、10^-3、10^-4、10^-5、10^-6、10^-7 mol·L^-1),分别取各浓度的金属离子溶液100μL与预制好的5种念珠菌悬液100μL进...     

Histopathology training in Europe: a lesson for other specialties?

Critical shortages of trained histopathologists limit the capacity of cancer and other clinical services. A survey of histopathology training in 18 European countries conducted by the European Union of Medical Specialists Section of Pathology/European Board of Pathology revealed a considerable shortage of both trained and trainee histopathologists in several of the responding countries. Demographic data indicate a high preponderance of trained histopathologists over 55 years of age and a notable proportion of part-time personnel. Although the training capacity in some countries has been increased, the immediate future of histopathology and the clinical services dependent on the specialty is worrisome. The histopathology workload is growing, and, in some countries, recruitment of trainees is insufficient for future needs. To avert the serious consequences for dependent clinical specialties and their patients, there should be a concerted European action to promote and expand histopathology training.     

Human Leucocyte Differentiation Antigen nomenclature: update on CD nomenclature. Report of IUIS/WHO Subcommittee

The 7th International Workshop on Human Leucocyte Differentiation Antigens (HLDA7) studied a number of newly characterised molecules relevant to human leucocyte differentiation and function. The HLDA organisation, which devised and continues to maintain the CD nomenclature, is responsible, under the auspices of IUIS and WHO, for the nomenclature of all leucocyte differentiation markers. The 7th Workshop redefined a number of (principally carbohydrate) molecules, and assigned CD names to approximately 80 new molecules. This update lists, in tabular form, the redefined and newly assigned names, together with antibodies, which have been confirmed under Workshop conditions as specific for the new and redefined molecules. The major features of the cellular expression patterns are summarised, and a LocusLink accession number provided to enable the reader to access more detailed information through http://www.ncbi.nlm.nih.gov/LocusLink.     

Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa

The aim of this study performed in Abidjan, C?te d'Ivoire, was to describe the distribution of CD4+ T-cell lymphocytes (CD4) in HIV-1-infected (HIV+) pregnant women diagnosed during prenatal voluntary counseling and testing and to assess whether HIV-related immunodeficiency influenced the acceptance of an antiretroviral (ARV) package (zidovudine beginning at 36 weeks of amenorrhea plus intrapartum nevirapine) to prevent mother-to-child transmission. Between April and June 2002, a CD4 count was systematically performed in all HIV+ women (n=221) in 5 antenatal clinics carrying out voluntary counseling and testing. No difference in CD4 count was found in HIV+ women who did not return for their test result (n=50) and those who were informed of their positive serostatus (n=171) (median CD4 count: 389/mm3 vs. 420/mm3; P=0.19). We also found a lack of difference in CD4 count in those who accepted ARV (n=72) and those who did not but knew their HIV status (n=99) (median CD4 count: 405/mm3 vs. 425/mm3; P=0.47). The overall uptake of the intervention (31.9%) appeared to be independent of the maternal immune status.